This month’s Back to Basics feature is a useful optimal value pathway on cardiovascular disease prevention from NHS RightCare. The pathway shows a number of elements of an optimal CVD prevention pathway including the evidence base, clinical interventions, information on the risk conditions and potential opportunities for improvement.
Many patients with atrial fibrillation are treated with direct oral anticoagulants (DOACs) to reduce the risk of stroke. To maintain patient safety, clinicians must be educated on how to manage DOACs, from safe prescribing to managing complications. A recent audit shows the potential for inadequate monitoring when compared to local clinical protocols.
This article reviews the important and growing role of the NHS Health Check in tackling some of the challenges in prevention and treatment of CVD and other non-communicable diseases.
This month’s Back to Basics summarizes the main features of the key direct oral anticoagulants (DOACs or NOACS). These drugs are becoming a standard therapy in many settings including stroke prevention, management of deep vein thrombosis and pulmonary embolism, and prevention of venous thromboembolism following hip and knee replacement.
ESC/EACTS guidelines for Valvular Heart Disease (VHD) management were updated in 2017 and has since impacted individual patient suitability for Aortic Stenosis treatment. A visual summary of the latest VHD management guidelines is now available. Download yours now!
This month’s Back to Basics feature is a patient information card that is included in the 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation. The card can be folded into pocket size and is crucial both for the patient and for healthcare providers.
This NHS Health Check overview shows the target age groups and risk factors assessed during the process. All these details should be recorded on the primary care record. The overview highlights the risk assessment, lifestyle management, clinical assessment and risk management processes involved in the NHS Health Check.
Cardiovascular disease is a much more preventable issue than many healthcare professionals realise. Medical advances, together with reduced premature mortality from CVD and increased life expectancy, means that on top of the demands of an ageing population we are also living ‘less-well’ for longer, and creating a different kind of pressure on services.
The concept of primary prevention of cardiovascular disease is certainly not new, and although much work has been done, there appears to be a drive to think differently about the way in which such initiatives are delivered. The workplace offers a convenient alternative environment to the conventional health care setting where employees can receive health and well-being services, including health checks and educational sessions.
Heart failure (HF) is a devastating clinical syndrome characterised by a constellation of symptoms and signs in the presence of reduced cardiac function. Comorbidity is almost inherent as HF is often the culmination of chronic disease processes such as ischaemic heart disease, hypertension and valve disease and its treatment may precipitate comorbidities such as gout, erectile dysfunction (ED) and acute kidney injury (AKI).
Cardiovascular disease (CVD) is the leading cause of death in Ireland and diminishes quality of life and places a burden on health care services. There is little known about CVD with regard to nurses’ health in Ireland. The overall aim of this study was to assess the lifestyle of cardiac nurses working in an acute setting for the first time in Ireland. These findings may have implications for primary care nurses.